Full-Time

Junior Verification & Validation Test Engineer

DEKA Research & Development Corp.

DEKA Research & Development Corp.

501-1,000 employees

Independent R&D lab developing medical devices

No salary listed

Manchester, NH, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Quality Assurance (QA)

Get referred to DEKA Research & Development Corp.

See people who can refer or advise you

Requirements
  • A Bachelor of Science degree in Physics, Biology, Electrical Engineering, Mechanical Engineering, or Biomedical Engineering is required.
  • Experience with research, development, and product testing is required.
  • Experience writing procedures for others to follow is required.
  • Experience with data and failure analysis is required.
  • Broad knowledge of measurement instruments is required.
  • Deep understanding of engineering fundamentals is required.
  • Demonstrated problem-solving ability and techniques are required.
  • Ability to work as part of an interdisciplinary team is required.
  • Ability to self-prioritize is required.
  • Ability to clearly explain objectives is required.
  • Attention to detail and strong verbal and written communication skills are required.
Responsibilities
  • Develop and write test procedures assessing the end-to-end performance and reliability of user interfaces and hardware.
  • Understand device design and core technologies to inform test method development.
  • Determine test coverage for design revisions.
  • Create and evaluate test fixtures as needed for product design verification.
  • Contribute to design failure investigations that may affect risk assessments, hazard analyses, and failure modes and effects analyses.
  • Contribute to regulatory and agency submissions.
  • Author test summaries and other documents.
Desired Qualifications
  • Experience with medical devices, knowledge of FDA Quality System Regulations, knowledge of ISO 13485, and other medical device industry experience.
DEKA Research & Development Corp.

DEKA Research & Development Corp.

View

DEKA Research & Development Corp. is a leading engineering R&D lab in Manchester, New Hampshire that develops a wide range of practical technologies and devices. It operates by interdisciplinary teams of engineers, machinists, designers, and technicians who take ambitious ideas and turn them into tangible products using advanced design and manufacturing methods. The company differentiates itself through its culture of hands-on experimentation, diverse project portfolio, and a track record of bringing to market or translating ideas into real-world applications. Its goal is to create technologies with a positive, lasting impact on people’s lives by solving meaningful problems.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Manchester, New Hampshire

Founded

1982

Get referred to DEKA Research & Development Corp.

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Diatech acquisition on October 7, 2025 deepened DEKA’s diabetes delivery stack.
  • Emergex collaboration keeps DEKA’s intradermal applicator active across 2026 biotech pipelines.
  • Revelio counted 872 employees in March 2026, and hiring stayed active.

What critics are saying

  • Sequel Med Tech drives twiist commercialization; any 2026 launch miss starves DEKA royalties.
  • Dean Kamen’s February 2026 Epstein scrutiny pressures recruiting, partnerships, and nonprofit ties.
  • DEKA’s revenue depends on a narrow medical-device portfolio; one regulatory failure hurts everything.

What makes DEKA Research & Development Corp. unique

  • Dean Kamen’s 1982 engineering bench produced LUKE, iBOT, and twiist.
  • DEKA owns core infusion and microneedle IP, not just outsourced design.
  • FDA cleared twiist in 2025, proving repeatable regulated-device execution.

Help us improve and share your feedback! Did you find this helpful?

Company News

Emergex Vaccines Holding Limited
Jan 16th, 2024
Emergex Announces R&D Collaboration with DEKA Research & Development Corp. for Assessment of Emergex's Immunotherapeutic Candidates with DEKA's Intradermal Therapeutic Applicator

- Emergex has entered into an agreement with DEKA Research & Development ('DEKA') to assess the compatibility of Emergex's T cell-priming set-point immunotherapeutic candidates with DEKA's Intradermal Therapeutic Applicator.

Business Wire
Oct 13th, 2022
Revolutionary And Affordable New Robotics System Makes Debut At 2022 First Global Challenge = A Win For Stem Equity

The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world. The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world